Inhaled antibiotics in mechanically ventilated patients

Area of Science:

• Pulmonology
• Infectious Diseases
• Critical Care Medicine

Background:

• Inhaled antibiotics, particularly colistin, are increasingly used for multidrug-resistant (MDR) Gram-negative nosocomial and ventilator-associated pneumonia (VAP).
• Antimicrobial aerosols are common in mechanically ventilated patients, but efficacy and administration techniques require further study.

Purpose of the Study:

• To review the current evidence on inhaled antibiotics for VAP management.
• To highlight the need for more randomized controlled trials (RCTs) to establish the efficacy and safety of inhaled antibiotics.

Main Methods:

• Review of recent studies and clinical practice regarding inhaled antibiotics for VAP.
• Analysis of existing data on the use of aerosolized antibiotics in mechanically ventilated patients.

Main Results:

• Recent studies suggest inhaled antibiotics, combined with systemic therapy, yield encouraging results with low toxicity for MDR Gram-negative VAP.
• Despite theoretical benefits, limited RCT data exist to support routine use, and regulatory approval is lacking.

Conclusions:

• While promising, the routine use of inhaled antibiotics for VAP lacks robust evidence from RCTs.
• Further research is urgently needed to define the role of inhaled antibiotics, alone or with parenteral therapy, in treating VAP caused by MDR bacteria.